ALFA FinderNSE filing, NSE: HCLTECH. Summary written from the filing by ALFA Finder's alert engine.
HCL Technologies Ltd: key numbers
- Share price
- ₹1,407.00
- Market cap
- ₹3,81,813 Cr
- Revenue (annual)
- ₹1,30,144 Cr
- Net profit (annual)
- ₹16,642 Cr
- P/E (TTM)
- 20.8×Sector 23.6×
- Promoter holding
- 60.88%+0.00% QoQ
- FII holding
- 15.32%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from HCL Technologies Ltd
All →HCL Technologies Other Announcement
HCL Technologies disclosed insider trades by designated persons and relatives, including RSU share receipt and market sales. No promoter involvement; routine insider-trading compliance disclosure.
HCL Technologies Product Launch
HCLTech launched AI-Powered Operations for mainframe environments, combining AI agents with mainframe expertise. The offering targets enterprise customers modernizing mission-critical systems.
HCL Technologies Acquisition
HCL Technologies completed its acquisition of Robotic Process Automation d.o.o. (Robotiq.ai) via a step-down subsidiary on October 26, 2026. This update follows the September 28, 2026 intimation of the 100% stake deal.
HCL Technologies Other Announcement
HCLTech expanded its Climate Action Grant to 24 countries, with winners due June 5, 2027. Awards total ₹11.88 Crore ($1.25 million) across one winner and three runner-ups.
- Value
- ₹11.88 Cr
HCL Technologies Partnership
HCLTech and Rapidus Corporation inaugurated a strategic partnership with two dedicated semiconductor engineering centers in Bengaluru and Hubli. No contract value was disclosed.
- semiconductor engineering centers
- 2 development centers
HCL Technologies Product Launch
HCLTech launched its NVIDIA-powered V&V for Auto offering to transform software-defined vehicle validation. The AI-driven solution automates validation workflows using agentic AI and simulation.
Other product launch announcements
All →Morepen Laboratories Product Launch
Morepen launched Desloratadine Tablets USP 5 mg, its first US prescription generic, through subsidiary Morepen Bio Inc. It also filed a Sitagliptin ANDA with the US FDA.
AstraZeneca Pharma India Product Launch
AstraZeneca Pharma India will launch Datverzo, Datopotamab Deruxtecan, in India in November 2026. The drug holds DCGI import and market permission for HR-positive, HER2-negative breast cancer.
Raama Finance Product Launch
Raama Finance launched 'Rupya Lelo', a digital lending platform offering instant personal loans, on October 6, 2026. The product is available only in India, and no loan amount or financial figure is disclosed.
Puravankara Product Launch
Puravankara will launch the residential project Purva Cityspire Phases 1, 2 and 3 in Ernakulam on 15 November 2026. The project is RERA-registered and is being developed by two wholly owned subsidiaries.
JBM Auto Product Launch
JBM Electric Vehicles launched the all-electric ECOLIFE e12 city bus at Singapore Urban Mobility Week 2026. It cites 20,000-bus annual capacity and a new Singapore APAC hub.
- electric bus manufacturing capacity
- 20000.0 buses per annum
Restaurant Brands Asia Product Launch
Burger King India launches a limited-edition Avengers: Doomsday Collection across nationwide restaurants. The menu features themed burgers, sides, and merchandise starting at ₹199.